Breast cancer: intraoperative radiotherapy to reduce treatment burden
Breast cancer remains the most common cancer in women. While chances of cure are improving thanks to early screening and new therapies, the journey often remains long and exhausting.
Each step – surgery, chemotherapy, radiotherapy – is accompanied by fatigue, anxiety and upheavals to daily life.
One therapeutic innovation is changing the game today: intraoperative radiotherapy, which makes it possible to shorten treatment while limiting the risk of recurrence.
A breakthrough: treating during the operation
Traditionally, after breast surgery, the patient had to undergo several weeks of radiotherapy to eliminate residual cancer cells.
With intraoperative radiotherapy:
-
The rays are delivered directly in the operating theater, immediately after the tumor is removed.
-
The targeted area is treated on the spot, even before the surgical procedure is finished.
-
Cancer cells invisible to the naked eye are destroyed immediately.
Result: in many cases, no additional radiotherapy sessions are needed.
Concrete benefits for patients
-
A shorter treatment: radiotherapy is concentrated into a single procedure.
-
Less fatigue and fewer trips: no more weeks of daily round trips to the hospital.
-
Reduced cost: resources can be reinvested in well-being, nutrition, or reconstruction.
-
A quicker return to social and family life: fewer medical constraints, more time for oneself.
Limitations and precautions
This promising technique is not suitable for all patients. Current criteria include:
-
an age between 55 and 66 years,
-
a small localized tumor (≈ 20 mm),
-
limited cell proliferation,
-
a physical condition compatible with the use of radiotherapy.
Furthermore, the method has not yet received official validation from health authorities. Ongoing clinical studies should confirm its long-term efficacy and safety.
RENASCOR: supporting rebirth after cancer
Reducing the duration of treatments is a huge advancement. But for many patients, the battle does not end with recovery. Visible aftereffects – notably hair loss – remain painful and symbolic of the disease.
This is where the RENASCOR Laboratory comes in:
-
With the REDACTIV1 protocol, which promotes healing and prepares regrowth.
-
With the REDACTIV2 serum, which stimulates density and supports hair reconstruction.
-
With a human and personalized follow-up, which puts the patient back at the center of her journey of renewal.
Because beyond treating, it is about restoring confidence, dignity and identity.
Conclusion
Intraoperative radiotherapy represents a medical advance that could transform the lives of thousands of women with breast cancer: a shorter, less burdensome and less traumatic treatment.
At RENASCOR, we believe that every innovation that eases the therapeutic journey is a victory. And we are committed to standing by patients to offer them, after recovery, a true hair and personal rebirth.
